As filed with the Securities and Exchange Commission on August 15, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
ANTERIX INC.
(Exact name of registrant as specified in its charter)
| Delaware | 33-0745043 | |
| (State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) | |
| 3 Garret Mountain Plaza Suite 401 Woodland Park, NJ |
07424 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
Anterix Inc. 2023 Stock Plan
(Full title of the plan)
Gena Ashe
Chief Legal Officer and Corporate Secretary
Anterix Inc.
3 Garret Mountain Plaza
Suite 401
Woodland Park, NJ 07424
(Name and address of agent for service)
(973) 771-0300
(Telephone number, including area code, of agent for service)
Copy to:
Kevin Collins, Esq.
Alexander J. May, Esq.
Jenner & Block LLP
1155 Avenue of the Americas
New York, NY 10036
(212) 891-1635
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
| Emerging growth company | ☐ | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 is filed by Anterix Inc. to register an additional 1,100,000 shares of Anterix Inc. common stock available for issuance under the Anterix Inc. 2023 Stock Plan (as amended the “Plan”). The 1,100,000 shares of common stock being registered on this Registration Statement are in addition to the 250,000 shares of common stock registered pursuant to a Form S-8 Registration Statement, No. 333-273981, filed with the Securities and Exchange Commission on August 14, 2023 (the “2023 Registration Statement”).
This Registration Statement relates to securities of the same class as to which the 2023 Registration Statement relates and is submitted in accordance with General Instruction E to Form S-8 regarding Registration of Additional Securities. Pursuant to General Instruction E of Form S-8, the contents of the 2023 Registration Statement, to the extent relating to the registration of common stock issuable under the Plan, are incorporated herein by reference and made part of this Registration Statement, except as amended, supplemented, or superseded hereby.
As of the August 8, 2023 effective date of the Plan, no further grants may be made under the Anterix Inc. 2014 Stock Plan (the “2014 Plan”) and shares that are subject to outstanding awards under the 2014 Plan that subsequently are lapsed, expired, terminated, cancelled or forfeited without a distribution of shares will become available for awards under the Plan. Accordingly, shares under the 2014 Plan previously registered pursuant to Registration Statements Nos. 333-201699, 333-209543, 333-215934, 333-222890, 333-229565, 333-236251, and 333-257115 that become available for awards under the Plan in accordance with its terms are also covered by the 2023 Registration Statement and this Registration Statement.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
Incorporated by reference to the Exhibit Index attached hereto.
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Woodland Park, State of New Jersey, on August 15, 2024.
| ANTERIX INC. |
| /s/ Robert H. Schwartz |
| Robert H. Schwartz |
| President and Chief Executive Officer |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below constitutes and appoints Robert Schwartz, Timothy Gray and Gena Ashe, and each and any of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and any registration statement relating to the same offering as this registration statement that is to be effective upon filing pursuant to Rule 462(b) of the Securities Act of 1933, and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or either of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
| /s/ Robert H. Schwartz |
President, Chief Executive Officer and Director (Principal Executive Officer) | August 15, 2024 | ||
| Robert H. Schwartz | ||||
| /s/ Timothy Gray |
Chief Financial Officer (Principal Financial and Accounting Officer) | August 15, 2024 | ||
| Timothy Gray | ||||
| /s/ Morgan O’Brien |
Executive Chairman of the Board | August 15, 2024 | ||
| Morgan O’Brien | ||||
| /s/ Jeffrey A. Altman |
Director | August 15, 2024 | ||
| Jeffrey A. Altman | ||||
| /s/ Leslie B. Daniels |
Director | August 15, 2024 | ||
| Leslie B. Daniels | ||||
| /s/ Mark A. Fleischhauer |
Director | August 15, 2024 | ||
| Mark A. Fleischhauer | ||||
| /s/ Thomas R. Kuhn |
Director | August 15, 2024 | ||
| Thomas R. Kuhn | ||||
| /s/ William E. Heard |
Director | August 15, 2024 | ||
| William E. Heard | ||||
| /s/ Scott A. Lang |
Director | August 15, 2024 | ||
| Scott A. Lang | ||||
| /s/ Mahvash Yazdi |
Director | August 15, 2024 | ||
| Mahvash Yazdi | ||||
EXHIBIT INDEX
| * | Filed herewith. |